Since MusclePharma was mentioned for comparison in HIMR's

New Post Public Reply Private Reply Replies (2) Message Board
Kgem
Since MusclePharma was mentioned for comparison in HIMR's blog post, board members might be interested in a little information and analysis on this company.


Blast Off Time For MusclePharm: $12 Million Offer is Complete

Chris Schmidt I think your analysis of the company’s upside as a potential investment is very good. This is a high-growth, best-in-class producer in a category expected [...] Richard Finger , Contributor Thanks for the excellent insight. As I think about it, perhaps you are right. Maybe a big pharma company with an aim towards nutrion and health would be a [...]

Comment Now

Follow Comments Following Comments Unfollow Comments

MusclePharm (MSLP), one of the leading healthy lifestyle companies in America providing specialty supplements for athletes of all genres, from professionals down to those long past their prime like me, has succeeded in raising $12 million in new equity. It was an impressive show of confidence that this offering was fully subscribed so quickly. The company has used the proceeds of the offering to pay down all of its debt and rid itself of nearly all of its dilutive warrant obligations,- leaving its balance sheet in pristine condition. This incredibly fast growing company which, in its less than five-year history, has been long on sales but short on profitability, is perfectly poised to turn things around in 2013. Although 2012 revenues came in at $78 million, an impressive 370 percent gain from 2011 sales of $17 million, the company has continued to bleed red ink. Ex-pro football player, founder and CEO Brad Pyatt has avoided a key pitfall that undermines many a small business owner. Many entrepreneurs are loath to significantly dilute their ownership. The concept that it is far better to own a smaller piece of something with great growth potential versus a significant amount of something that is weak and underfunded has been elusive for many executives in Mr. Pyatt’s position. Mr. Pyatt looked trouble in the eye and exhibited his perspicacity-realizing that without more capital, all that he had worked for might go down the drain. Years of narrow gross margins and perhaps a bloated overhead structure had placed MusclePharm in a perilous working capital position. Each share of the completed offering of Series D convertible preferred stock at $8.00 is convertible into two shares of MusclePharm common shares . After the full conversion common shares will have increased from three to six million shares and Mr. Pyatt will have diluted his ownership by 50 percent.

As mentioned in my previous article, the lead investor in this offering was billionaire pharmaceutical investor Dr. Phillip Frost , the current chairman of Israeli drug giant Teva Pharmaceuticals. Dr. Frost doubled his original subscription commitment in the offering to $2.9 million, or nearly a quarter of total funds raised. As the company has grown in size, so has its clout with its manufacturers. Renegotiated supply agreements will radically improve company gross margins and Mr. Pyatt has also made significant overhead reductions. A new distribution center will save money both through centralized fulfillment and reduction of delivery times- creating opportunity to turn over inventories more frequently. For a more complete synopsis of operational savings, see my previous article.

Behind all the numbers are products that obviously work, and, regardless of intentions, Mr. Pyatt has created a cult-like following. I viewed a number of You Tube videos that left me thinking that MusclePharm is like a religion of the healthy. The company strives to address not only muscle building but also weight loss and general fitness through daily nutritional supplement regimens. There is a state-of-the-art fitness facility at the company’s Denver corporate headquarters where professional athletes from near and far come to train and work with MusclePharm scientists. All MusclePharm merchandise is rigorously tested for safety and efficacy and new products are always being formulated.

So What Could MusclePharm Be Worth

So let’s revisit some valuation metrics now that the company officially has a clean, debt-free balance sheet and is poised for profitability. In its recent 8K report, Mr. Pyatt publicly announced a conservative (in my opinion) 2013 revenue guidance of at least $100 million. Given the past year’s triple-digit revenue growth, the new streamlined fulfillment capabilities, vast networks of distribution, as well as cash from the offering for expansion, I predict sales for this year will reach at least $120 million. The main publicly-traded comparable company was formerly NYSE-traded Schiff Nutrition International which this past November agreed to a buyout by British consumer products maker Reckitt Benkiser Group for $1.4 billion. The prior twelve months revenues for Schiff were $285 million which equates to a purchase price of almost five times sales. This metric is probably not appropriate for MusclePharm at this time given its current lack of profitability. Schiff had five year average gross margins of just under 41 percent. Even more relevant they registered average five year pre-tax margins of 10.1 percent and net profit margins of 6.4 percent. If, and it means if, MusclePharm registers $120 million in 2013 and achieves a 6.4% after-tax margin this performance would translate to a profit of nearly $7.7 million. On a post-offering six million fully diluted shares, this hypothetical performance would equate to a valuation of about $1.28 per share. Pre-acquisition, for the trailing six years, Schiff Nutrition traded at an average P/E of 16. At that multiple, MusclePharm would achieve a market cap of $123 million-equating to a share price of $20.50 at a reasonable 1x sales. MusclePharm’s profile, however, is far different from Schiff’s. MusclePharm is in a very fast growing niche of specialized supplements promoting high performance as well as healthy living while Schiff is in a more slow growth traditional vitamin market. So why then was a British conglomerate eager to pay five times sales and compete in a bidding war with German Pharmaceutical giant Bayer AG for the prize of the lumbering Schiff Nutrition? The answer probably lies in the operating synergies gained from simply adding the Schiff product lines into their already existing distribution and fulfillment systems while concurrently slicing or eliminating significant percentages of Schiff’s own system. The planned synergies from the acquisition, assuming they can be achieved, may make this deal accretive for Reckitt in as few as three or four years…..which brings us back to MusclePharm.

Mr. Pyatt has a stated goal of reaching $500 million in sales. I predict that, within three years, if MusclePharm can reach revenues of $200 million and maintain after-tax profit margins of 5-8 percent the company will attract the attention of some of the giant suitors in the consumer products space. Coca-Cola (KO) or Pepsi (PEP) might easily pay several times revenues for a product that could easily be put in their distribution systems. This is the same economies of scale argument I made above. A company like MusclePharm could also grow faster under the global umbrella of a KO. Also manufacturing costs for MusclePharm would likely fall with Coca-Cola as payment guarantor. With MusclePharm as a $200 million company, it would signal to a buyer that they have a firmly established brand and are likely here to stay. Another possible marriage partner may be the smaller Dr. Pepper Snapple Group; market capitalization –wise, it is less than a twelfth the size of Pepsi and a twentieth of Coca-Cola. Perhaps they might pay more as the acquisition could “move their needle” more quickly, meaning it could show up more meaningfully in their earnings sooner than in the financials  of behemoths KO or PEP. If an acquirer paid three time revenues on $200 million, this would equate to a purchase price of $600 million or $100 per share on the current base of six million shares. In three years, assuming management awards stock options I assume will be granted, let’s predict that there are 6.4 (hopefully fewer) million shares outstanding, so the buyout price now gets reduced to $93.75 per share.

What Can Go Wrong

When the share offering was first announced, MSLP spiked from a little over $4 per share to nearly $8.00 in fewer than ten trading days. The stock has since settled in the $5.50 range. The hype is over, and shareholders rightly are now waiting to see whether this commitment to profitability is the real deal. There is always a chance that Mr. Pyatt can’t show the discipline necessary to make the company into a sustaining cash flow generating business. Additionally, maybe MusclePharm turns into a passing fad. Right now as lead nutrition supplier for the red hot Ultimate Fighting Championships, MusclePharm with its highly visible logo is everywhere in the media, so brand awareness is high. Many a high flying brand has crashed and burned with frightening speed. Also, the supplement business is very competitive and new innovations and claims of better mousetraps are always trying to knock the top dog off the pedestal. In my conversations with Mr. Pyatt, his confidence is palpable…..but actions will speak louder than words. Good luck to him.

http://www.forbes.com/sites/richardfinger/201...-complete/

Hollund Industrial Marine Inc. (HIMR) Stock Research Links

HIMR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 110

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 93

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 167

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 118

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 162

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 165

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 205

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 87

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 126

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading

Top 5 Most Recently Viewed Articles

Avaline's Organic Wines Shine in New Holiday Campaign

Updated Category News Views 250

Avaline Unveils Its Charming Holiday Campaign The organic wine brand Avaline is excited to kick off its holiday campaign, which beautifully captures the spirit of the season. By blending nostalgia with festive cheer, Avaline invites everyone to relish the little moments that make the holidays special. The campaign draws inspiration from beloved holiday films, reminding us...

Continue Reading
Exploring In-Game Advertising: Key Insights for Brands

Updated Category News Views 206

Unlocking the Potential of In-Game Advertising Recent research conducted by Cint sheds light on the rising value of in-game advertising (IGA) for brands and the necessity for measurement standards within this dynamic marketing field. Video games have increasingly become a vital platform for advertisers, offering rich engagement opportunities. Consumers are showing...

Continue Reading
Mawson Infrastructure Reports Significant Operational Growth

Updated Category News Views 66

Update on Mawson Infrastructure Group's Operations Mawson Infrastructure Group Inc. recently released a significant operational update that highlights impressive growth in its digital colocation sector. The figures show a remarkable 166% increase in digital colocation revenue compared to a year ago, specifically in August 2023, and a solid 25% growth from the previous...

Continue Reading
Cybersecurity Landscape Evolves: New Threats and Insights

Updated Category News Views 292

An Overview of Current Cybersecurity Threats The digital landscape is becoming increasingly complex, and organizations are challenged with new and emerging cybersecurity threats. Red Canary's recent report dives deep into these threats, highlighting alarming trends that security teams must address now. The Rise of Identity Attacks As technology continues to advance, so do...

Continue Reading
US Family Health Plan Brighton Marine Celebrates Recognition with Awards

Updated Category News Views 188

US Family Health Plan Brighton Marine Honored with Excellence Awards Recent accolades reflect the dedication and quality of care provided by US Family Health Plan Brighton Marine. This esteemed organization has been awarded three Human Experience Pinnacle of Excellence Awards, recognizing it as one of the top health plans across the nation. Such recognition highlights the...

Continue Reading